cardiovascular

Bayer Plans to Scale Back Women’s Health R&D

Ahead of a change in leadership at the top after the upcoming annual general meeting, in interviews with news agencies Bayer is dropping hints in dribbles about future plans for its healthcare business.

News

AstraZeneca Sells Heart Drug Rights to Recordati

News

Sanofi and Regeneron Appeal Praluent Sales Halt

Topics • Chemistry

Scottish Ingenuity

Top-Feature

Together for Sustanability (TFS)

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Interview

The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

cardiovascular

Bayer Plans to Scale Back Women’s Health R&D

AstraZeneca Sells Heart Drug Rights to Recordati

Sanofi and Regeneron Appeal Praluent Sales Halt

Scottish Ingenuity

Top-Feature

Driving Sustainability Through Collaboration

Leading the way. Driving results.

Leading Transformation

API Manufacturing

Brenntag Downsizes Management Board, Retains Both Divisions

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Anchored in Sustainability

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Interview

Leading Transformation

Newsletter & e-edition